The US CD38 Monoclonal Antibodies Market is benefiting from substantial investment in multiple myeloma research. Clinical trials and academic research are evaluating CD38-targeted therapies across different disease stages and combination regimens. The CD38 Monoclonal Antibodies Market size is expected to reach US$ 20.63 Billion by 2034 from US$ 8.99 Billion in 2025, registering a CAGR of 9.67%...

The Antibody Drug Conjugates Market is expanding as oncology research increasingly focuses on targeted therapies that can selectively deliver potent drug payloads to cancer cells. ADCs combine antibody-based targeting with cytotoxic agents to create specialized treatment approaches. The Antibody Drug Conjugates Market size is projected to reach US$ 38,077.45 million by 2031 from US$ 8,105.65...

The US Biosimilars Market is benefiting from growing regulatory experience and increasing availability of biosimilar products. Greater familiarity among physicians, pharmacists, and healthcare organizations is supporting broader integration into treatment pathways. The Biosimilars Market size is expected to grow from US$ 18,435.89 million in 2021 to US$ 136,069.53 million by 2028, registering...

The North America Liquid Biopsy Market is supported by sophisticated diagnostic infrastructure and strong investment in cancer research. The region's focus on precision medicine is encouraging the development and adoption of advanced molecular testing technologies. The Liquid Biopsy Market was estimated at US$ 4.57 billion in 2021 and is expected to reach US$ 12.69 million by 2031, registering...

The Continuous Glucose Monitoring Device (CGMD) Market is expanding as diabetes management increasingly shifts toward continuous and data-driven monitoring. These devices provide ongoing glucose readings, helping users and healthcare professionals better understand changes in glucose levels throughout the day. The Continuous Glucose Monitoring Device (CGMD) Market size is projected to reach US$...

The US Surgical Robotics Market is supported by advanced hospital infrastructure and strong adoption of minimally invasive surgical technologies. Major medical centers are increasingly incorporating robotic platforms into surgical programs across specialties. The Surgical Robotics Market size is projected to reach US$ 28.54 billion by 2031 from US$ 10.25 billion in 2023, registering a CAGR of...

The North America CBCT Dental Imaging Market is also being shaped by technological advancements in dental imaging systems. Improvements in image processing, workflow integration, and equipment design are helping expand the role of CBCT across dental practices. The CBCT Dental Imaging market was valued at US$ 548.85 million in 2025 and is expected to reach US$ 1,009.79 million by 2034,...

The Cardiometabolic Disease Market is being driven by the rising prevalence of obesity and metabolic disorders worldwide. Changes in dietary patterns, sedentary lifestyles, and population aging are contributing to a broader patient population requiring long-term disease management. The cardiometabolic disease market is expected to reach US$ 155.56 billion by 2034 from US$ 109.28 billion in...

The US Cabozantinib Market is supported by a well-established oncology care infrastructure and widespread access to specialized cancer treatment. The country's strong focus on precision medicine also supports the clinical evaluation and use of targeted therapies. The Cabozantinib Market was valued at US$ 1.46 billion in 2025 and is expected to reach US$ 2.67 billion by 2034, registering a CAGR...

The North America Blood Compatible Polymers Market is supported by advanced healthcare infrastructure and a strong medical-device manufacturing ecosystem. The region's focus on cardiovascular care and innovative biomaterials is creating demand for specialized polymer technologies. The Blood Compatible Polymers Market size is expected to reach US$ 6.88 billion by 2031, registering a CAGR of...